RxDoctor Payments Data

James Jakub, MD

Surgical Oncology · Jacksonville, FLNPI 1447243431

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (45.5%), consulting fees and education — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 67.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $3,702 and has fallen 81.0% since, to $702 in 2025.

$12,022in general payments, 2019–2025

Across 63 payments — averaging $190.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$8K
  • Novartis$3K
  • Axogen$542
  • Iovance Biotherapeutics, Inc.$470
  • Medtronic$44
  • Merck$18
$122,082in research payments, 2019–2025

Across 14 payments — averaging $8720.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intuitive Surgical Operations, Inc.$122K

What the payments were for

  • Consulting fees$2,84024%
  • Travel & lodging$5,46745%
  • Food & beverage$1,82115%
  • Education$1,89416%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical52$8,108
Novartis1$2,840
Axogen3$542
Iovance Biotherapeutics, Inc.5$470
Medtronic1$44
Merck1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,022 in reported general payments places this provider in the 80th percentile of 133 surgical oncology providers in Florida.

See all surgical oncology providers in Florida

Medicare billing

Part B allowed, 2024
$125,878
Medicare patients
145
Services billed
475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →